Background:
Based on the long history of medicinal use of Thunbergia laurifolia, Clerodendrum disparifolium and Rotheca serrata, the extract formulations of these species: T. laurifolia and C. disparifolium; T. laurifolia and R. serrata;and T. laurifolia, C. disparifolium and R. serrata, called formulas 1, 2 and 3, were created for detoxification testing to take more advantage of eachspecies.
Objective:
To estimate the detoxifying effects of studiedextract formulations on human cell and tissue culture as a preclinical trial.
Methods:
Themajor phytochemicals were derived by GC-MS. Thedetoxification efficacy of these formulations in cellsand DNA levelsby MTT and cometassays in toxic PBMCs (incubated with rice whisky or bathroom cleaner).
Results:
The phytochemical constituents were detected at 23.48% phytol and 43.03% oleamide in T. laurifolia; 12.88% oleamide, 20.93% 9,12,15-octadecatrien, 25.52% squalene, 22.19% butylated hydroxy toluene and 15.36% vitamin E in C. disparifolium; and 30.41% phytol, 32.78% oleamide, and12.20%, 9,12,15-octadecatrien-1-ol in R. serrata.The toxic cells treated with the plant formulas 1, 2 and 3 showed no IC50 values,but formulas 1 and 2 displayed higher efficaciesthandid formula 3. The comet assay indicated that the experiments (the treatment on toxic cells with the plant formulas) induced significant (p<0.05) DNA damage compared to the negative control due to poisoning occurring before administration of the plant formulas. The OTM of the controls was significantly (p<0.05) longer than the experimental samplesshowing significantly reduce toxicityof the created formulations.
Conclusion:
The formulas showed high detoxification efficacies and the formulations 1 and 2resulted inhigher levels of detoxification thanthe formulation3, especially immediate treatment after receiving toxic substances.